|
|
|
2020 Nelson's Pediatric Antimicrobial Therapy (0026) (Paperback)
原價:
HK$370.00 
現售:
HK$351.5
節省:
HK$18.5 購買此書 10本或以上 9折, 60本或以上 8折
抱歉! 此商品已售罄, 不能訂購
|
|
|
商品簡介 |
The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens. New in the 26th edition: - First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
- Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
- Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
- Updates on management of influenza, including baloxavir (now approved for children >12 years)
- New approaches to treatment of mucomycosis
- New recommendations for malaria
- More than 150 new references
|
|
|
|
|
|
